2015-2027 Global Neuroendocrine Tumor Treatment Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

April 2020 | 112 pages | ID: 28E710146EBFEN
Maia Research

Abstracts

The worldwide market for Neuroendocrine Tumor Treatment is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
AVEO Oncolog
Boehringer Ingelheim International GmbH
Pfizer, Inc
Novartis AG
Ipsen Pharma

Major Types Covered
Somatostatin Analogs (SSAs)
Targeted Therapy
Others

Major Applications Covered
Lungs
Pancreas
Colon
Small Intestine
Others

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027

Contents

1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Neuroendocrine Tumor Treatment Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Neuroendocrine Tumor Treatment Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE NEUROENDOCRINE TUMOR TREATMENT MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL NEUROENDOCRINE TUMOR TREATMENT MARKET-SEGMENTATION BY TYPE

5.1 Somatostatin Analogs (SSAs)
5.2 Targeted Therapy
5.3 Others

6 GLOBAL NEUROENDOCRINE TUMOR TREATMENT MARKET-SEGMENTATION BY APPLICATION

6.1 Lungs
6.2 Pancreas
6.3 Colon
6.4 Small Intestine
6.5 Others

7 GLOBAL NEUROENDOCRINE TUMOR TREATMENT MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 AVEO Oncolog
  8.1.1 AVEO Oncolog Profile
  8.1.2 AVEO Oncolog Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 AVEO Oncolog Product/Solution Launches and Enhancements Analysis
  8.1.4 AVEO Oncolog Business Overview/Recent Development/Acquisitions
8.2 Boehringer Ingelheim International GmbH
  8.2.1 Boehringer Ingelheim International GmbH Profile
  8.2.2 Boehringer Ingelheim International GmbH Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 Boehringer Ingelheim International GmbH Product/Solution Launches and Enhancements Analysis
  8.2.4 Boehringer Ingelheim International GmbH Business Overview/Recent Development/Acquisitions
8.3 Pfizer, Inc
  8.3.1 Pfizer, Inc Profile
  8.3.2 Pfizer, Inc Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 Pfizer, Inc Product/Solution Launches and Enhancements Analysis
  8.3.4 Pfizer, Inc Business Overview/Recent Development/Acquisitions
8.4 Novartis AG
  8.4.1 Novartis AG Profile
  8.4.2 Novartis AG Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 Novartis AG Product/Solution Launches and Enhancements Analysis
  8.4.4 Novartis AG Business Overview/Recent Development/Acquisitions
8.5 Ipsen Pharma
  8.5.1 Ipsen Pharma Profile
  8.5.2 Ipsen Pharma Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Ipsen Pharma Product/Solution Launches and Enhancements Analysis
  8.5.4 Ipsen Pharma Business Overview/Recent Development/Acquisitions

9 GLOBAL NEUROENDOCRINE TUMOR TREATMENT MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Neuroendocrine Tumor Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Neuroendocrine Tumor Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Neuroendocrine Tumor Treatment Production Analysis from 2015-2020
10.4 North America Neuroendocrine Tumor Treatment Consumption Analysis from 2015-2020
10.5 North America Neuroendocrine Tumor Treatment Import and Export from 2015-2020
10.6 North America Neuroendocrine Tumor Treatment Value, Production and Market Share by Type (2015-2020)
10.7 North America Neuroendocrine Tumor Treatment Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Neuroendocrine Tumor Treatment by Country (United States, Canada)
  10.8.1 North America Neuroendocrine Tumor Treatment Sales by Country (2015-2020)
  10.8.2 North America Neuroendocrine Tumor Treatment Consumption Value by Country (2015-2020)
10.9 North America Neuroendocrine Tumor Treatment Market PEST Analysis

11 EUROPE

11.1 Europe Neuroendocrine Tumor Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Neuroendocrine Tumor Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Neuroendocrine Tumor Treatment Production Analysis from 2015-2020
11.4 Europe Neuroendocrine Tumor Treatment Consumption Analysis from 2015-2020
11.5 Europe Neuroendocrine Tumor Treatment Import and Export from 2015-2020
11.6 Europe Neuroendocrine Tumor Treatment Value, Production and Market Share by Type (2015-2020)
11.7 Europe Neuroendocrine Tumor Treatment Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Neuroendocrine Tumor Treatment by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Neuroendocrine Tumor Treatment Sales by Country (2015-2020)
  11.8.2 Europe Neuroendocrine Tumor Treatment Consumption Value by Country (2015-2020)
11.9 Europe Neuroendocrine Tumor Treatment Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Neuroendocrine Tumor Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Neuroendocrine Tumor Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Neuroendocrine Tumor Treatment Production Analysis from 2015-2020
12.4 Asia-Pacific Neuroendocrine Tumor Treatment Consumption Analysis from 2015-2020
12.5 Asia-Pacific Neuroendocrine Tumor Treatment Import and Export from 2015-2020
12.6 Asia-Pacific Neuroendocrine Tumor Treatment Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Neuroendocrine Tumor Treatment Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Neuroendocrine Tumor Treatment by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Neuroendocrine Tumor Treatment Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Neuroendocrine Tumor Treatment Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Neuroendocrine Tumor Treatment Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Neuroendocrine Tumor Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Neuroendocrine Tumor Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Neuroendocrine Tumor Treatment Production Analysis from 2015-2020
13.4 Latin America Neuroendocrine Tumor Treatment Consumption Analysis from 2015-2020
13.5 Latin America Neuroendocrine Tumor Treatment Import and Export from 2015-2020
13.6 Latin America Neuroendocrine Tumor Treatment Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Neuroendocrine Tumor Treatment Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Neuroendocrine Tumor Treatment by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Neuroendocrine Tumor Treatment Sales by Country (2015-2020)
  13.8.2 Latin America Neuroendocrine Tumor Treatment Consumption Value by Country (2015-2020)
13.9 Latin America Neuroendocrine Tumor Treatment Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Neuroendocrine Tumor Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Neuroendocrine Tumor Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Neuroendocrine Tumor Treatment Production Analysis from 2015-2020
14.4 Middle East & Africa Neuroendocrine Tumor Treatment Consumption Analysis from 2015-2020
14.5 Middle East & Africa Neuroendocrine Tumor Treatment Import and Export from 2015-2020
14.6 Middle East & Africa Neuroendocrine Tumor Treatment Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Neuroendocrine Tumor Treatment Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Neuroendocrine Tumor Treatment by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Neuroendocrine Tumor Treatment Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Neuroendocrine Tumor Treatment Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Neuroendocrine Tumor Treatment Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL NEUROENDOCRINE TUMOR TREATMENT MARKET FROM 2020-2027

15.1 Future Forecast of the Global Neuroendocrine Tumor Treatment Market from 2020-2027 Segment by Region
15.2 Global Neuroendocrine Tumor Treatment Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Neuroendocrine Tumor Treatment Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Global Neuroendocrine Tumor Treatment Market Value ($) and Growth Rate of Neuroendocrine Tumor Treatment from 2015-2027
Global Neuroendocrine Tumor Treatment Production and Growth Rate Segment by Product Type from 2015-2027
Global Neuroendocrine Tumor Treatment Consumption and Growth Rate Segment by Application from 2015-2027
Figure Neuroendocrine Tumor Treatment Picture
Table Product Specifications of Neuroendocrine Tumor Treatment
Table Driving Factors for this Market
Table Industry News of Neuroendocrine Tumor Treatment Market
Figure Value Chain Status of Neuroendocrine Tumor Treatment
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Neuroendocrine Tumor Treatment Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Neuroendocrine Tumor Treatment Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Somatostatin Analogs (SSAs) of Neuroendocrine Tumor Treatment
Figure Targeted Therapy of Neuroendocrine Tumor Treatment
Figure Others of Neuroendocrine Tumor Treatment
Table Global Neuroendocrine Tumor Treatment Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Neuroendocrine Tumor Treatment Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Lungs of Neuroendocrine Tumor Treatment
Figure Pancreas of Neuroendocrine Tumor Treatment
Figure Colon of Neuroendocrine Tumor Treatment
Figure Small Intestine of Neuroendocrine Tumor Treatment
Figure Others of Neuroendocrine Tumor Treatment
Table Global Neuroendocrine Tumor Treatment Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Neuroendocrine Tumor Treatment Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Neuroendocrine Tumor Treatment
Figure Online Channel of Neuroendocrine Tumor Treatment
Table AVEO Oncolog Profile (Company Name, Plants Distribution, Sales Region)
Figure AVEO Oncolog Sales and Growth Rate from 2015-2020
Figure AVEO Oncolog Revenue ($) and Global Market Share from 2015-2020
Table AVEO Oncolog Neuroendocrine Tumor Treatment Sales, Price, Revenue, Gross Margin (2015-2020)
Table Boehringer Ingelheim International GmbH Profile (Company Name, Plants Distribution, Sales Region)
Figure Boehringer Ingelheim International GmbH Sales and Growth Rate from 2015-2020
Figure Boehringer Ingelheim International GmbH Revenue ($) and Global Market Share from 2015-2020
Table Boehringer Ingelheim International GmbH Neuroendocrine Tumor Treatment Sales, Price, Revenue, Gross Margin (2015-2020)
Table Pfizer, Inc Profile (Company Name, Plants Distribution, Sales Region)
Figure Pfizer, Inc Sales and Growth Rate from 2015-2020
Figure Pfizer, Inc Revenue ($) and Global Market Share from 2015-2020
Table Pfizer, Inc Neuroendocrine Tumor Treatment Sales, Price, Revenue, Gross Margin (2015-2020)
Table Novartis AG Profile (Company Name, Plants Distribution, Sales Region)
Figure Novartis AG Sales and Growth Rate from 2015-2020
Figure Novartis AG Revenue ($) and Global Market Share from 2015-2020
Table Novartis AG Neuroendocrine Tumor Treatment Sales, Price, Revenue, Gross Margin (2015-2020)
Table Ipsen Pharma Profile (Company Name, Plants Distribution, Sales Region)
Figure Ipsen Pharma Sales and Growth Rate from 2015-2020
Figure Ipsen Pharma Revenue ($) and Global Market Share from 2015-2020
Table Ipsen Pharma Neuroendocrine Tumor Treatment Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Neuroendocrine Tumor Treatment Production Value ($) by Region from 2015-2020
Table Global Neuroendocrine Tumor Treatment Production Value Share by Region from 2015-2020
Table Global Neuroendocrine Tumor Treatment Production by Region from 2015-2020
Table Global Neuroendocrine Tumor Treatment Consumption Value ($) by Region from 2015-2020
Table Global Neuroendocrine Tumor Treatment Consumption by Region from 2015-2020
Table North America Neuroendocrine Tumor Treatment Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Neuroendocrine Tumor Treatment Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Neuroendocrine Tumor Treatment Import and Export from 2015-2020
Table North America Neuroendocrine Tumor Treatment Value ($) by Type (2015-2020)
Table North America Neuroendocrine Tumor Treatment Production by Type (2015-2020)
Table North America Neuroendocrine Tumor Treatment Consumption by Application (2015-2020)
Table North America Neuroendocrine Tumor Treatment Consumption by Country (2015-2020)
Table North America Neuroendocrine Tumor Treatment Consumption Value ($) by Country (2015-2020)
Figure North America Neuroendocrine Tumor Treatment Market PEST Analysis
Table Europe Neuroendocrine Tumor Treatment Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Neuroendocrine Tumor Treatment Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Neuroendocrine Tumor Treatment Import and Export from 2015-2020
Table Europe Neuroendocrine Tumor Treatment Value ($) by Type (2015-2020)
Table Europe Neuroendocrine Tumor Treatment Production by Type (2015-2020)
Table Europe Neuroendocrine Tumor Treatment Consumption by Application (2015-2020)
Table Europe Neuroendocrine Tumor Treatment Consumption by Country (2015-2020)
Table Europe Neuroendocrine Tumor Treatment Consumption Value ($) by Country (2015-2020)
Figure Europe Neuroendocrine Tumor Treatment Market PEST Analysis
Table Asia-Pacific Neuroendocrine Tumor Treatment Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Neuroendocrine Tumor Treatment Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Neuroendocrine Tumor Treatment Import and Export from 2015-2020
Table Asia-Pacific Neuroendocrine Tumor Treatment Value ($) by Type (2015-2020)
Table Asia-Pacific Neuroendocrine Tumor Treatment Production by Type (2015-2020)
Table Asia-Pacific Neuroendocrine Tumor Treatment Consumption by Application (2015-2020)
Table Asia-Pacific Neuroendocrine Tumor Treatment Consumption by Country (2015-2020)
Table Asia-Pacific Neuroendocrine Tumor Treatment Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Neuroendocrine Tumor Treatment Market PEST Analysis
Table Latin America Neuroendocrine Tumor Treatment Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Neuroendocrine Tumor Treatment Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Neuroendocrine Tumor Treatment Import and Export from 2015-2020
Table Latin America Neuroendocrine Tumor Treatment Value ($) by Type (2015-2020)
Table Latin America Neuroendocrine Tumor Treatment Production by Type (2015-2020)
Table Latin America Neuroendocrine Tumor Treatment Consumption by Application (2015-2020)
Table Latin America Neuroendocrine Tumor Treatment Consumption by Country (2015-2020)
Table Latin America Neuroendocrine Tumor Treatment Consumption Value ($) by Country (2015-2020)
Figure Latin America Neuroendocrine Tumor Treatment Market PEST Analysis
Table Middle East & Africa Neuroendocrine Tumor Treatment Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Neuroendocrine Tumor Treatment Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Neuroendocrine Tumor Treatment Import and Export from 2015-2020
Table Middle East & Africa Neuroendocrine Tumor Treatment Value ($) by Type (2015-2020)
Table Middle East & Africa Neuroendocrine Tumor Treatment Production by Type (2015-2020)
Table Middle East & Africa Neuroendocrine Tumor Treatment Consumption by Application (2015-2020)
Table Middle East & Africa Neuroendocrine Tumor Treatment Consumption by Country (2015-2020)
Table Middle East & Africa Neuroendocrine Tumor Treatment Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Neuroendocrine Tumor Treatment Market PEST Analysis
Table Global Neuroendocrine Tumor Treatment Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Neuroendocrine Tumor Treatment Production and Growth Rate Forecast by Region (2020-2027)
Table Global Neuroendocrine Tumor Treatment Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Neuroendocrine Tumor Treatment Production and Growth Rate Forecast by Type (2020-2027)
Table Global Neuroendocrine Tumor Treatment Consumption and Growth Rate Forecast by Application (2020-2027)